Commercial Access Only

Specimen SS-COM-BTR-0012 // BITTER

Brassica Clear T1-PR-PH

Brassica oleracea var. italica

Broccoli

Brassica Clear SeriesTier 1

Target Trait

20

% reduction

Reported target: 20% bitter reduction

Technical Specifications

Genomic Edits

4

GC Content

(43%)

Construct Length

4,740 bp

Promoter System

Ubiquitin / T7

Expression System

Protoplast PEG-fusion

Host Strain

PEG-mediated

Pathway Edits

  • TAS2R38 partial suppression
  • Glucosinolate pathway attenuation

Key Interventions

TAS2R38 RNAi knockdown constructSinigrin reduction via glucosinolate pathway attenuation

Application Domains

PharmaceuticalResearch

Intended Use

Pharmaceutical excipient and nutraceutical formulation — bitterness-masked brassica extracts and active compounds for clinical and supplement applications

Access

Request Commercial Access

This construct is available exclusively to qualified institutions. Submit an inquiry to receive technical documentation and licensing terms.

Contact Us →

No pricing is listed publicly. We respond to all qualified inquiries within 2 business days.

Back to Commercial Catalog